These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23744364)

  • 1. ▾Glycopyrronium for COPD.
    Drug Ther Bull; 2013 Jun; 51(6):66-8. PubMed ID: 23744364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycopyrronium bromide for the treatment of chronic obstructive pulmonary disease.
    Riario-Sforza GG; Ridolo E; Riario-Sforza E; Incorvaia C
    Expert Rev Respir Med; 2015 Feb; 9(1):23-33. PubMed ID: 25547422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glycopyrronium bromide is a long-acting inhaled anticholinergic in the treatment of severe COPD].
    Ulrik CS
    Ugeskr Laeger; 2013 Aug; 175(35):1946-8. PubMed ID: 23978116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily glycopyrronium via the Breezhaler® device for the treatment of COPD: pharmacological and clinical profile.
    Molimard M; D'Andrea P
    Expert Rev Clin Pharmacol; 2013 Sep; 6(5):503-17. PubMed ID: 23971870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with indacaterol and glycopyrronium bromide in the management of COPD: an update on the evidence for efficacy and safety.
    Ridolo E; Montagni M; Riario-Sforza GG; Baroni M; Incorvaia C
    Ther Adv Respir Dis; 2015 Apr; 9(2):49-55. PubMed ID: 25691493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebulized glycopyrrolate (Lonhala Magnair) for COPD.
    Med Lett Drugs Ther; 2018 Apr; 60(1543):72. PubMed ID: 29667949
    [No Abstract]   [Full Text] [Related]  

  • 7. Once-daily glycopyrronium bromide (Seebri Breezhaler(®)) for the treatment of chronic obstructive pulmonary disease (COPD).
    Ulrik CS
    Expert Opin Pharmacother; 2015; 16(17):2653-9. PubMed ID: 26641535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NVA237, a long-acting muscarinic antagonist, as an emerging therapy for chronic obstructive pulmonary disease.
    Vogelmeier C; Banerji D
    Ther Adv Respir Dis; 2011 Jun; 5(3):163-73. PubMed ID: 21511677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glycopyrronium, by inhalation and oral administration (Seebri)].
    Peeters S; Warnez M
    J Pharm Belg; 2013 Dec; (4):37-8. PubMed ID: 24449973
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety and tolerability of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients.
    Vogelmeier C; Verkindre C; Cheung D; Galdiz JB; Güçlü SZ; Spangenthal S; Overend T; Henley M; Mizutani G; Zeldin RK
    Pulm Pharmacol Ther; 2010 Oct; 23(5):438-44. PubMed ID: 20416390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profile of inhaled glycopyrronium bromide as monotherapy and in fixed-dose combination with indacaterol maleate for the treatment of COPD.
    Prakash A; Babu KS; Morjaria JB
    Int J Chron Obstruct Pulmon Dis; 2015; 10():111-23. PubMed ID: 25609944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled glycopyrronium bromide: a review of its use in patients with moderate to severe chronic obstructive pulmonary disease.
    Carter NJ
    Drugs; 2013 May; 73(7):741-53. PubMed ID: 23677802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential for long-acting muscarinic antagonists in chronic obstructive pulmonary disease.
    Joos GF
    Expert Opin Investig Drugs; 2010 Feb; 19(2):257-64. PubMed ID: 20047505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indacaterol/glycopyrronium: a dual bronchodilator for COPD.
    Banerji D; Fogel R; Patalano F
    Drug Discov Today; 2018 Jan; 23(1):196-203. PubMed ID: 29079130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ▾Indacaterol for COPD.
    Drug Ther Bull; 2012 May; 50(5):58-60. PubMed ID: 22573707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seebri Neohaler and Utibron Neohaler for COPD.
    Med Lett Drugs Ther; 2016 Mar; 58(1491):39-41. PubMed ID: 27027687
    [No Abstract]   [Full Text] [Related]  

  • 17. Once-daily glycopyrronium bromide, a long-acting muscarinic antagonist, for chronic obstructive pulmonary disease: a systematic review of clinical benefit.
    Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2012; 7():673-8. PubMed ID: 23055716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycopyrrolate/eFlow CS: The First Nebulized Long-Acting Muscarinic Antagonist Approved to Treat Chronic Obstructive Pulmonary Disease.
    Pleasants RA
    Ann Pharmacother; 2019 Mar; 53(3):285-293. PubMed ID: 30175596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycopyrrolate/formoterol (Bevespi Aerosphere) for COPD.
    Med Lett Drugs Ther; 2016 Oct; 58(1505):130-132. PubMed ID: 27701364
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and safety of nebulized glycopyrrolate for administration using a high efficiency nebulizer in patients with chronic obstructive pulmonary disease.
    Leaker BR; Barnes PJ; Jones CR; Tutuncu A; Singh D
    Br J Clin Pharmacol; 2015 Mar; 79(3):492-500. PubMed ID: 25243340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.